Dendreon

Dendreon Posts Wider Than Expected Q4 Loss, But Revenues Up YoY (DNDN) What To Watch: March 1st, 2011 The Week Ahead: February 28th, 2011 Medicare Decides Provenge Can Be Reimbursed // Pharmalot The unsurprising decision comes just four months after a CMS advisory panel voted that Dendreon’s Provenge vaccine for advanced prostate cancer shows “clinically significant” improvement in survival (look here). The panel was convened, … Medicare to pay for $93000 prostate cancer drug (AP) | MacHelp … The Centers for Medicare and Medicaid said the biotech drug made by Dendreon Corp. is a “reasonable and necessary” medicine. The decision ensures that thousands of men will be able to receive the drug through the federal government. … Japan Fukuoka Stock-PR » Blog Archive » (PPWE, DNDN, LAYN, LULU … Dendreon Corp. (Nasdaq:DNDN) announced that management will present at the following conferences:Needham Healthcare Conference, New York, NY on April 6, 2011 at 10:00 a.m. ET. Leerink Swann Cancer Roundtable Conference, New York, … (PPWE, DNDN, LAYN, LULU) Stock Updates by Stock-PR.com | crwenews.com Dendreon Corp. (Nasdaq:DNDN) announced that management will present at the following conferences:Needham Healthcare Conference, New York, NY on April 6, 2011 at 10:00 a.m. ET. Leerink Swann Cancer Roundtable Conference, New York, … UPDATE 1-US Medicare plans to cover Dendreon's Provenge Medicare: adequate evidence for prostate cancer vaccine * Final decision due June 30 LOS ANGELES, March 30 (Reuters) – Men in the U.S. Medicarehealth insurance program will get full coverage of DendreonCorp’s … Cancer_MFH says: Dendreon Prostate Cancer Drug Proposed in Medicare Coverage – Bloomberg: WFMY News 2Dendreon Prostate Canc… http://tinyurl.com/4rt9sgb

Posted by on March 30, 2011. Filed under News. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.